CoStar Group, Inc. (CSGP) Tops Q4 EPS by 3c; Guides In-Line
Tweet
Share
E-mailGet Alerts CSGP Hot Sheet
Price: $31.12 -1.14%
Financial Fact:
Purchase amortization: 5.55M
Today's EPS Names:
CPHC, ROLR, EROC, More
Financial Fact:
Purchase amortization: 5.55M
Today's EPS Names:
CPHC, ROLR, EROC, More
Join SI Premium – FREE
CoStar Group, Inc. (NASDAQ: CSGP) reported Q4 EPS of $0.46, $0.03 better than the analyst estimate of $0.43. Revenue for the quarter came in at $100.1 million versus the consensus estimate of $98.17 million.
CoStar Group, Inc. sees Q1 2013 EPS of $0.41-0.45, versus the consensus of $0.42. CoStar Group, Inc. sees Q1 2013 revenue of $101-103 million, versus the consensus of $101.95 million.
CoStar Group, Inc. sees FY2013 EPS of $2.08-2.20, versus the consensus of $2.13. CoStar Group, Inc. sees FY2013 revenue of $424-429 million, versus the consensus of $425.4 million.
For earnings history and earnings-related data on CoStar Group, Inc. (CSGP) click here.
CoStar Group, Inc. sees Q1 2013 EPS of $0.41-0.45, versus the consensus of $0.42. CoStar Group, Inc. sees Q1 2013 revenue of $101-103 million, versus the consensus of $101.95 million.
CoStar Group, Inc. sees FY2013 EPS of $2.08-2.20, versus the consensus of $2.13. CoStar Group, Inc. sees FY2013 revenue of $424-429 million, versus the consensus of $425.4 million.
For earnings history and earnings-related data on CoStar Group, Inc. (CSGP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Transact Technologies (TACT) Tops Q2 EPS by 1c
- Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
